As of October 2026 Halozyme Therapeutics has a market cap of ยฃ11.09 Billion. This makes Halozyme Therapeutics the world's 1451th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 30th, 2026 the market cap of Halozyme Therapeutics was reported to be: